Enroll in this course to get access You don't currently have access to this contentYou don't currently have access to this contentYou don't currently have access to this content
0

Concomitant Use of β-Blockers & Sulfonylureas Ups Risk for Severe Hypoglycemia

Concomitant Use of β-Blockers & Sulfonylureas Ups Risk for Severe Hypoglycemia

Concomitant Use of β-Blockers & Sulfonylureas Ups Risk for Severe Hypoglycemia

By June 2, 2023

Concomitant Use of β-Blockers & Sulfonylureas Ups Risk for Severe Hypoglycemia

Concomitant Use of β-Blockers & Sulfonylureas Ups Risk for Severe Hypoglycemia

Current Status
Not Enrolled
Price
Free
Get Started

This course discusses how the concomitant use of β-blockers and sulfonylureas increases the risk for severe hypoglycemia and how to gain aware of other medications that, when given together with sulfonylureas, increase the risk for hypoglycemia.

Click CE Information to start the course. Post Test and Evaluation must be completed to earn certificate of completion.

Concomitant Use of β-Blockers & Sulfonylureas Ups Risk for Severe Hypoglycemia

Expand All
Lesson Content
0% Complete 0/1 Steps